Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs PRU✓SelectedUSD · PRUGSK vs PRU performance historyLatest closeAs of-2.71%09/08
Stock and ETF performance explorer

GSK vs PRU

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+76.8%
PRU return
+139.4%
Excess return
-62.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioPRUExcessAlpha
1D-2.7%-2.2%-0.5%-2.3%
7D-4.2%+1.9%-6.1%-4.5%
30D-7.5%-0.4%-7.1%-7.5%
3M-3.3%+16.4%-19.7%-6.2%
6M-9.3%+26.0%-35.4%-13.5%
YTD+1.6%+9.9%-8.3%-0.6%
1Y+25.5%+18.8%+6.7%+20.7%
3Y+49.3%+45.3%+3.9%+35.4%
5Y+46.7%+45.6%+1.1%+31.3%
10Y+76.8%+139.6%-62.8%+24.3%
All+76.8%+139.4%-62.6%+24.3%

Cumulative growth

Daily Returns

Daily percentage return beside PRU.

Daily Out/Under-Performance

Portfolio return minus PRU return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × PRU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded PRU wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling